DMD and Duchenne muscular dystrophy: Further studies were focused on the preclinical optimisation of drisapersen, testing its efficacy on young and older DMD mouse model, mdx. This mouse model is characterised by an induced nonsense point mutation in the dystrophin gene, which leads to a loss of functional protein expression [108].